Open AccessCASE OF SECONDARY THROMBOTIC THROMBOCYTOPENIC PURPURA TRIGGERED BY COVID-19
Author(s) -
R. E. Yakubtsevich,
Ye. V. Zukhovitskaya,
К. М. Дорохин,
N. F. Vasilevskaya
Publication year - 2021
Publication title -
žurnal grodnenskogo gosudarstvennogo medicinskogo universiteta
Language(s) - English
Resource type - Journals
eISSN - 2413-0109
pISSN - 2221-8785
DOI - 10.25298/2221-8785-2021-19-5-541-545
Subject(s) - thrombotic thrombocytopenic purpura , adamts13 , rituximab , medicine , methylprednisolone , covid-19 , thrombocytopenic purpura , therapeutic plasma exchange , immunology , platelet , antibody , disease , infectious disease (medical specialty)
The article analyzes a clinical case of the development of thrombotic thrombocytopenic purpura (TTP) in a patient with verified COVID-19 infection. The algorithm of TTP diagnosis when ADAMTS13 biomarker test is unavailable is presented. The article presents the scheme of effective treatment of TTP with the use of plasma exchange, methylprednisolone and rituximab administration.